NU SKIN ENTERPRISES INC - A (NUS) Stock Price, Quote, News and Overview
NYSE:NUS - New York Stock Exchange, Inc. - US67018T1051 - Common Stock - Currency: USD
NUS Quote, Performance and Key Statistics
NU SKIN ENTERPRISES INC - A
NYSE:NUS (2/5/2025, 4:15:00 PM)
After market: 6.44 0 (0%)6.44
-0.07 (-1.08%)
The current stock price of NUS is 6.44 USD. In the past month the price decreased by -7.47%. In the past year, price decreased by -63.41%.
NUS Latest News, Press Releases and Analysis
Nu Skin (NUS) Shares Skyrocket, What You Need To Know
Shares of personal care company Nu Skin (NYSE:NUS) jumped 13.3% in the morning session after the company reported strong preliminary Q4 2024 guidance, with revenue expected to be at the high end of the previous guidance range. A day after this report, the company is expected to share updates on its strategy, including the recent sale of Mavely for $250 million. Overall, the updates provide more reasons for investors to stay optimistic.
Nu Skin Enterprises Announces Q4 Preliminary Revenue at High End of Guidance
Nu Skin (NUS) Shares Skyrocket, What You Need To Know
Shares of personal care company Nu Skin (NYSE:NUS) jumped 21.9% in the morning session after the company announced the sale of the Mavely affiliate technology platform, owned by its subsidiary Rhyz Inc., to Later, a marketing and social media management software firm. Valued at $250 million, the deal delivered a substantial payoff, with management adding, "This transaction yielded roughly a fivefold return on the company's total investment in Mavely since its acquisition in 2021."
Why Is Nu Skin Enterprises Stock Jumping Today?
Nu Skin Enterprises, Inc. (NYSE:NUS) saw its shares rise on Friday following the announcement of a strategic transaction by its Rhyz Inc. subsidiary. Rhyz has sold its Mavely affiliate marketing technology platform to Later, a portfolio company of Summit Partners, for approximately $250 million in cash and a minority equity stake in the combined Later/Mavely business. The deal, which also includes $33 million to be paid to other equity holders in the Mavely business, is part of Nu Skin’s broader
Why Is Nu Skin Enterprises Stock Jumping Today?
Nu Skin's stock rose premarket on Friday following the announcement of its Rhyz subsidiary selling the Mavely platform to Later for $250 million.
NUS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 21.03 | 144.07B | ||
| HLN | HALEON PLC-ADR | 56.65 | 43.54B | ||
| KVUE | KENVUE INC | 17.43 | 39.76B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 27.82 | 23.67B | ||
| BRBR | BELLRING BRANDS INC | 36.78 | 9.87B | ||
| COTY | COTY INC-CL A | 16.17 | 5.91B | ||
| ELF | ELF BEAUTY INC | 27.81 | 4.92B | ||
| IPAR | INTERPARFUMS INC | 29.83 | 4.45B | ||
| ODD | ODDITY TECH LTD-CL A | 24.87 | 2.73B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 10.41 | 1.55B | ||
| OLPX | OLAPLEX HOLDINGS INC | 11.54 | 994.38M | ||
| HNST | HONEST CO INC/THE | N/A | 633.02M |
Related stock screener links
About NUS
Company Profile
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. The company is headquartered in Provo, Utah and currently employs 3,700 full-time employees. The firm develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The firm has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. The company develops and distributes products in two categories, beauty products and wellness products. The firm operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
Company Info
NU SKIN ENTERPRISES INC - A
Attn: D. Matthew Dorny, 75 West Center St
Provo UTAH 84601 US
CEO: Ritch N. Wood
Employees: 3700
Company Website: https://www.nuskin.com/
Investor Relations: https://ir.nuskin.com/
Phone: 18013456100
NUS FAQ
What is the stock price of NUS?
The current stock price of NUS is 6.44 USD.
What is the symbol for NU SKIN ENTERPRISES INC - A stock?
The exchange symbol of NU SKIN ENTERPRISES INC - A is NUS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NUS stock listed?
NUS stock is listed on the New York Stock Exchange, Inc. exchange.
Is NUS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NUS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NUS.
Does NUS stock pay dividends?
NUS has a dividend yield of 3.46%. The yearly dividend amount is currently 1.57.
When does NUS stock report earnings?
NUS will report earnings on 2025-02-13, after the market close.
What is the Price/Earnings (PE) ratio of NUS?
The PE ratio for NUS is 7.67. This is based on the reported non-GAAP earnings per share of 0.84 and the current share price of 6.44 USD.
What is the Short Interest ratio of NUS stock?
The outstanding short interest for NUS is 4.82% of its float.
NUS Technical Analysis
NUS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NUS. NUS has only an average score on both its financial health and profitability.
NUS Financial Highlights
Over the last trailing twelve months NUS reported a non-GAAP Earnings per Share(EPS) of 0.84. The EPS decreased by -64.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.52% | ||
| ROE | -14.6% | ||
| Debt/Equity | 0.53 |
NUS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to NUS. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -62.93% and a revenue growth -11.94% for NUS